30 Jan, 2024 09:57 AM
-- Arovella has entered into a global, exclusive license with University of North CarolinaLineberger Comprehensive Cancer Center to incorporate a novel armouring cytokinetechnology (IL-12-TM) for it...read more
30 Jan, 2024 08:13 AM
Funds Received for Sale of 25% of Altech Industries Germany
-- Final instalment received of €1,583,333 of Deferred Consideration from Altech Advanced Materials AG (AAM), in relation to the sal...read more
27 Dec, 2023 04:49 PM
Austco Healthcare Limited (ASX: AHC) is pleased to announce that Teknocorp, its recently acquired subsidiary, has been awarded an AUD $1.2 million contract to deliver state-of-the-art access control...read more
21 Dec, 2023 08:19 AM
Highlights
Highly positive Definitive Feasibility Study (DFS) - 8,000tpa Silumina AnodesTM project
8,000 tpa alumina-coated metallurgical silicon only
Customers to blend coated...read more
30 Nov, 2023 01:45 PM
Melbourne, Australia, 30 November 2023: AD1 Holdings Limited (‘AD1’, the ‘Company’ or the ‘Group’) (ASX: AD1), a technology company with a growing portfolio of ma...read more
20 Nov, 2023 01:12 PM
Arovella Therapeutics Ltd (ASX: ALA), a biotechnology company focused on developing its invariant Natural Killer T (iNKT) cell therapy platform, is pleased to announce that it has received its FY202...read more